Spasticity Screener for Stroke
(ReIMage Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to evaluate the effectiveness of a spasticity screener and to determine if the spasticity screener results are useful to healthcare providers and impact clinical decision making
Who Is on the Research Team?
Sean I Savitz, MD
Principal Investigator
The University of Texas Health Science Center at Houston PO Box 20036
Are You a Good Fit for This Trial?
This trial is for adults who have experienced a stroke or brain bleed (intracerebral hemorrhage) and may be dealing with muscle stiffness or spasticity. Specific inclusion and exclusion criteria are not detailed, so eligibility will depend on the study site's assessment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Evaluation
Participants are evaluated using a spasticity screener to assess its effectiveness and impact on clinical decision making
Follow-up
Participants are monitored for safety and effectiveness after evaluation
What Are the Treatments Tested in This Trial?
Trial Overview
The study compares using a new screening tool for muscle stiffness (spasticity screener) versus usual care to see if it helps doctors make better treatment decisions for people after stroke.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor
AbbVie
Industry Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.